Header and Body 1


The invention describes methods and compositions for cardioprotection and regeneration using bivalent ligands from the epidermal growth factor (EGF) family. These methods have applications in anticancer therapeutics with dose-dependent cardiotoxic effects. Additionally, the invention serves to treat cardiotoxicity from compounds associated with alcohol and cocaine use.